MyGenetx teams with National Hockey League's Nashville Predators, to promote breast cancer awareness.
Online, October 1, 2015 (Newswire.com) - Advanced healthcare laboratory, MyGenetx, is sponsoring a breast cancer awareness event at Bridgestone Arena on Oct. 22, when the Nashville Predators host the Anaheim Ducks. For attendees, MyGenetx will offer information on BRCA1/2 genetic screenings and will provide a free BRCA1/2 screen to those who meet the suggested screening guidelines and have physician approval. In addition, MyGenetx will supply complimentary event shirts for all attendees.
BRCA1/2 are the most well-known genes linked to breast cancer risk.
We are excited to be working with the Predators and MyGenetx to bring awareness to TBCC and to educate women about BRCA screening. Jami Eller, Executive Director, TBCC
The Predators' organization will honor several middle-Tennessee breast cancer patients and survivors by providing game tickets, as well as rides on the Zamboni.
Attendees also have the opportunity to make donations to the event's featured charity, the Tennessee Breast Cancer Coalition (TBCC). The Nashville Predators Foundation will make a $1,000 contribution to the charity.
The Tennessee Breast Cancer Coalition, established in 1995, is a grassroots organization dedicated to improving the quality of life for individuals undergoing treatment for breast cancer. The TBCC mission is to be the foremost advocate and provider for Tennesseans facing breast cancer through individual assistance, education, and legislative action. In 2002, TBCC established the Emergency Access Fund to provide financial assistance to individuals in financial need due to inability to work and or mounting medical expenses incurred while undergoing treatment of breast cancer. This fund is designed to partner with other established community agencies to provide quick turn-around funding. This fund has provided assistance in preventing evictions, paying utilities, insurance and medical necessities. Recipients must be residents of Tennessee and currently undergoing breast cancer treatments. For more information about qualifications and how to receive assistance from this fund please call 615-377-8777.
"We are so excited to be working with the Predators and MyGenetx to bring awareness to Tennessee Breast Cancer Coalition and to also educate women about BRCA screening. We want women to know if they could have the inherited gene that puts them at a higher risk of developing breast cancer. We also want them to know that if they have been diagnosed with breast cancer, they are in treatment and struggling financially, TBCC may be able to help them with basic necessities like, rent, mortgage payments and utilities," says Jami Eller, Executive Director at TBCC
According to the National Cancer Institute, One in eight women are diagnosed with breast cancer each year. For women who are BRCA1/2 positive, the risk is one in two. It is reported that an estimated one in 500 women have a BRCA1/2 mutation, and in the Ashkenazi Jewish population, the number rises to one in 40.
MyGenetx is a CLIA certified molecular and general chemistry laboratory, providing timely and comprehensive test results. MyGenetx has a national footprint in the areas of Pharmacogenetics, Chronic Disease Management, Oncology, Women's Health, Corporate Wellness, Endocrinology, and Oral Health. MyGenetx is committed to bringing affordable, accessible, and actionable laboratory testing to everyone. Research and innovative ideas in genetic testing are at the forefront, allowing MyGenetx to offer personalized medicine and specialized healthcare options, beyond the traditional standard of care.
www.cancer.gov
www.tbcc.org
www.mygenetx.com
predators.nhl.com
Source URL: http://prweb.com/releases/2015/MyGenetx/prweb12994816.htm
Share: